Dr Matthias Pelzing
Honorary (Fellow)
Faculty of Science
69 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Proteoform-Resolved Interaction Studies of Plasminogen by CZE-MS and SEC-MS Under Near-Native Conditions
DOI: 10.1002/jms.700482025
Journal article
Apolipoprotein A1 (CSL112) Increases Lecithin-Cholesterol Acyltransferase Levels in HDL Particles and Promotes Reverse Cholesterol Transport
DOI: 10.1016/j.jacbts.2024.11.0012024
Journal article
Abstract 4138633: Infusion of human apolipoprotein A-I (CSL112) promotes several aspects of reverse cholesterol transport
DOI: 10.1161/circ.150.suppl_1.41386332024
Journal article
A mechanistic model of in vitro plasma activation to evaluate therapeutic kallikrein-kinin system inhibitors
DOI: 10.1371/journal.pcbi.10125522024
Journal article
Structural basis for the inhibition of βFXIIa by garadacimab
DOI: 10.1016/j.str.2024.07.0012024
Journal article
Mechanistic insights into complement pathway inhibition by CR1 domain duplication
DOI: 10.1016/j.jbc.2024.1074512023
Journal article
HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposure
DOI: 10.1080/19420862.2022.2163459
RECENT SCHOLARLY WORKS
2022
Journal article
Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence
DOI: 10.3390/jcm110306302020
Journal article
Butyrophilin molecules govern γδ T cell reactivity against phosphoantigens
DOI: 10.4049/jimmunol.204.supp.140.122020
Conference Proceedings
Butyrophilin molecules govern γδ T cell reactivity against phosphoantigens